ESC Premium Access

Identification of patients eligible to start sacubitril valsartan in a stable heart failure population

Congress Presentation

About the speaker

Doctor Suleman Aktaa

Leeds General Infirmary, Leeds (United Kingdom of Great Britain & Northern Ireland)
0 follower

8 more presentations in this session

Hemodynamic evaluation of patients with advanced heart failure receiving ambulatory intermittent cycles of levosimendan as bridge to transplant

Speaker: Doctor I. Hernandez Gonzalez (Valladolid, ES)


Cardiorenal protection by subcutaneous cenderitide in experimental heart failure: a novel and safe therapeutic for humans with LVAD support

Speaker: Doctor T. Ichiki (Rochester, US)


What proportion of patients with heart failure are candidates for sacubitril/valsartan? Differences between guideline recommendations and regulatory labels

Speaker: Doctor P. Pellicori (Glasgow, GB)


Initiation of sacubitril/valsartan in hospitalized patients with HFrEF after hemodynamic stabilization: baseline characteristics of the TRANSITION study compared with TITRATION and PARADIGM-HF

Speaker: Doctor M. Senni (Bergamo, IT)


Oral donepezil markedly suppresses the progression of cardiovascular remodeling and improves the prognosis in spontaneously hypertensive rats with myocardial infarction

Speaker: Doctor M. Li (Osaka, JP)


Access the full session

Poster Session 7 - Chronic heart failure – Treatment

Speakers: Doctor S. Aktaa, Doctor I. Hernandez Gonzalez, Doctor T. Ichiki, Doctor P. Pellicori, Doctor M. Senni...

About the event


ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by